Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00694174 · ClinicalTrials.gov registry record · Phase 4

Skin Blood Flow Changes Using Laser Doppler Imager for Assessment of Pain and Analgesia in Newborn Infants

A Phase 4 study of Procedural Pain, sponsored by Children's Hospital of Michigan.

Completed
Registry status
Phase 4
Development phase
56
Enrollment target
1
Study location

NCT00694174 is a Phase 4 study of Procedural Pain that has completed, run by Children's Hospital of Michigan. The registered enrollment target is 56 participants, roughly in line with the 55-participant average among 9 other Procedural Pain trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00694174, a Phase 4 study of Procedural Pain, has completed, sponsored by Children's Hospital of Michigan.

COMPLETED
Registry status
Phase 4
Development phase
56 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess whether an instrument, the Laser Doppler Imager, is able to measure the effect of pain related changes in skin blood flow in newborn infants. The study will also determine whether the use of sucrose (sugar water) when given by mouth has any effect on pain related skin blood flow changes.

Conditions Studied

Interventions

  • DRUG sucrose 24% oral solution
  • DRUG sterile water

Study Locations (1)

Michigan

  • Hutzel Women's University Hospital, The Detroit Medical Center - Detroit

Trial Details

FieldValue
Enrollment Target 56 participants
Start Date 2005-09
Est. Completion 2007-09
Phase Phase 4

Sponsor

Children's Hospital of Michigan

5 total trials

What the Registry Record Tells You About NCT00694174

The ClinicalTrials.gov registry entry for NCT00694174 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 55-participant average among 9 other Procedural Pain trials with a reported enrollment target. The listed sponsor is Children's Hospital of Michigan, which has 5 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Procedural Pain appearing as the primary indexed condition, and to 2 interventions - of which sucrose 24% oral solution is the first listed.

NCT00694174 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.

Frequently Asked Questions

What is clinical trial NCT00694174 about?

NCT00694174 is a clinical study titled "Skin Blood Flow Changes Using Laser Doppler Imager for Assessment of Pain and Analgesia in Newborn Infants". The purpose of this study is to assess whether an instrument, the Laser Doppler Imager, is able to measure the effect of pain related changes in skin blood flow in newborn infants. The study will also determine whether the use of sucrose (sugar water) when given by mouth has any effect on pain relat...

What is the current status of trial NCT00694174?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 56 participants. The study started on 2005-09. Estimated completion is 2007-09.

What conditions does trial NCT00694174 study?

This clinical trial studies the following conditions: Procedural Pain.

What interventions are being tested in trial NCT00694174?

The interventions under investigation include: sucrose 24% oral solution (DRUG), sterile water (DRUG).

Who is sponsoring clinical trial NCT00694174?

This trial is sponsored by Children's Hospital of Michigan, which has 5 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00694174 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Procedural Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.